CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $4.06B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.64: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.59%Below 5Y avg (1.69%)
Annual Rate
CNY 0.14Paid annual
Payout Ratio
79.5%Moderate
Last Ex-Dividend
Oct 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
27.13BCNY4.06B · vs all stocks (USD)
Trailing P/E
31.65xRevenue (TTM)
9.16BCNY1.37B · vs all stocks (USD)
Profit Margin
9.28%Beta
0.2640xvs all stocks
52-Week Change
46.65%vs all stocks
Market Capitalization
27.13BCNY4.06B · vs all stocks (USD)
Enterprise Value
24.85BCNY3.72B · vs all stocks (USD)
Trailing P/E
31.65xForward P/E
22.74xPrice to Sales (TTM)
2.96xPrice to Book (MRQ)
4.01xEnterprise to Revenue
2.71xEnterprise to EBITDA
15.55xGross Margin
29.80%Profit Margin
9.28%Operating Margin
13.12%Return on Assets (TTM)
4.70%Return on Equity (TTM)
12.75%Revenue (TTM)
9.16BCNY1.37B · vs all stocks (USD)
Revenue per Share (TTM)
7.95CNYUpdated Oct 18, 2026Quarterly Revenue Growth
-12.50%Gross Profit (TTM)
2.51BCNY376.08M · vs all stocks (USD)
EBITDA (TTM)
1.16BCNY173.78M · vs all stocks (USD)
Net Income (TTM)
850.01MCNY127.13M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-13.10%Operating Cash Flow (TTM)
887.35MCNY132.71M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-65.85MCNY-9.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1390CNYUpdated Oct 18, 2026Trailing Annual Dividend Yield
0.59%vs all stocks
5-Year Average Dividend Yield
1.69%vs all stocks
Payout Ratio
79.48%Minority Interest (Equity)
7.92MCNYFY2025 · Dec 31, 2025Revenue
9.78BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
7.20BCNYFY2025 · Dec 31, 2025Gross Profit
2.58BCNYFY2025 · Dec 31, 2025Operating Income
1.07BCNY159.54M · vs all stocks (USD)
Pre-tax Income
1.07BCNYFY2025 · Dec 31, 2025Income Tax Expense
175.52MCNYFY2025 · Dec 31, 2025Net Income
890.68MCNYFY2025 · Dec 31, 2025EBIT
1.09BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.84BCNYFY2025 · Dec 31, 2025Research & Development
611.17MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
550.46MCNYFY2025 · Dec 31, 2025Other Operating Expenses
60.29MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
112.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
24.65MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7723CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7723CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.15BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
890.68MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-3.70KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
847.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
494.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.92BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
890.68MCNYFY2025 · Dec 31, 2025Other Non-cash Items
43.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-227.87MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
141.26MCNYFY2025 · Dec 31, 2025Capital Expenditures
-353.19MCNYFY2025 · Dec 31, 2025Net Acquisitions
30.18MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.30BCNYFY2025 · Dec 31, 2025Sale of Investments
1.25BCNYFY2025 · Dec 31, 2025Other Investing Activity
-161.34KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-372.32MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.13BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.42BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-836.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
-525.88MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-643.09MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.16BSharesUpdated Oct 18, 2026Float Shares
505.68MSharesUpdated Oct 18, 2026% Held by Insiders
54.92%vs all stocks
% Held by Institutions
10.00%vs all stocks
Total Cash (MRQ)
3.06BCNY457.36M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.72CNYUpdated Oct 18, 2026Total Debt (MRQ)
1.53BCNY229.20M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2330xCurrent Ratio (MRQ)
1.58xBook Value per Share (MRQ)
5.83CNYUpdated Oct 18, 2026Total Assets
12.32BCNY1.84B · vs all stocks (USD)
Total Current Assets
7.88BCNYFY2025 · Dec 31, 2025Total Liabilities
5.97BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.44BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
606.76MCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.37BCNYFY2025 · Dec 31, 2025Cash
2.92BCNYFY2025 · Dec 31, 2025Cash Equivalents
864.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.79BCNYFY2025 · Dec 31, 2025Accounts Receivable
1.71BCNYFY2025 · Dec 31, 2025Inventory
1.60BCNYFY2025 · Dec 31, 2025Accounts Payable
3.38BCNYFY2025 · Dec 31, 2025Short-term Debt
1.07BCNYFY2025 · Dec 31, 2025Other Current Liabilities
246.87MCNYFY2025 · Dec 31, 2025Long-term Debt
487.21MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.16BCNYFY2025 · Dec 31, 2025Retained Earnings
5.11BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.35BCNY949.16M · vs all stocks (USD)
Treasury Stock
482.06MCNYFY2025 · Dec 31, 202552-Week Low
14.89CNYUpdated Oct 18, 202652-Week High
28.50CNYUpdated Oct 18, 202652-Week Change
46.65%vs all stocks
Beta
0.2640xvs all stocks
50-Day MA
23.59CNYUpdated Oct 18, 2026200-Day MA
19.40CNYUpdated Oct 18, 2026Avg 10-Day Volume
19.22MSharesUpdated Oct 18, 2026Avg 30-Day Volume
16.56MSharesUpdated Oct 18, 2026Diluted EPS (TTM)
0.7400CNYUpdated Oct 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.64: safe zoneNotable
Altman Z-Score: 4.64
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $4.06B, above the global median of $1.15BNotable
Market cap (USD): 4,057,674,752.988Global Median: 1,150,342,212.262
Revenue is $1.37B, above the global median of $559.35MNotable
Revenue (USD): 1,370,331,875Global Median: 559,350,010.583
Companies that share the same coordination system — how they create, deliver, or capture value.
J.B. Chemicals & Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tier 1ProductionApproval-Gated PipelineRule
Viking Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
AbCellera Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
China Medical System Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
Xuanzhu Biopharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Changchun High-Tech Industry Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tango Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
LivaNova PLC
Tier 1ProductionApproval-Gated PipelineRuleRisk